2 completed, 2 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 2 |
Follow cenegermin: new trials by email Literature Review of cenegermin trials Research Report on cenegermin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Cenegermin, Vehicle - Non-Arteritic Anterior Ischemic Optic Neuropathy | Phase 3 | Recruiting | Dompé Farmaceutici S.p.A | 272 | 2026-07-01 | 2026-10-27 |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED Cenegermin, Vehicle - Persistent Corneal Epithelial Defect | Phase 3 | Recruiting | Dompé Farmaceutici S.p.A | 150 | 2026-06-02 | 2026-10-07 |
| Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease Cenegermin, Vehicle - Dry Eye Disease | Phase 3 | Completed | Dompé Farmaceutici S.p.A | 85 | 2022-01-27 | 2025-11-26 |
| Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study) Oxervate, Vehicle - Dry Eye | Phase 3 | Completed | Dompé Farmaceutici S.p.A | 104 | 2022-01-19 | 2024-06-07 |
Dry Eye Syndromes (2) · Conjunctivitis, Allergic (1) · Optic Nerve Diseases (1) · Optic Neuropathy, Ischemic (1)
United States (4) · Italy (3) · South Korea (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Japan (1) · Mexico (1) · Netherlands (1) · Poland (1) · Spain (1)
2025 (1)